Effect of COVID-19 vaccination and SARS-CoV-2 infection status on mortality risk in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study
- PMID: 41484970
- DOI: 10.1186/s12931-025-03470-9
Effect of COVID-19 vaccination and SARS-CoV-2 infection status on mortality risk in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study
Keywords: COVID-19; Chronic obstructive pulmonary disease; Mortality; Respiratory disease; Vaccination.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study protocol was approved by the Institutional Review Board of Hanyang University Hospital (No. HYUH-2024-10-002). The requirement for informed consent was waived because all patient records were anonymized before use. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
References
-
- Contreras S, Iftekhar EN, Priesemann V. From emergency response to long-term management: the many faces of the endemic state of COVID-19. Lancet Reg Health Eur. 2023;30:100664.
-
- Centers for Disease Control and Prevention. People with certain medical conditions and COVID-19 risk factors. https://www.cdc.gov/covid/risk-factors/index.html . Accessed 24 Aug 2024.
-
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for Prevention, diagnosis and management of COPD: 2024 Report. Updated 2024. http://goldcopd.org/2024-gold-report . Assess 27 July 2024.
-
- Centers for Disease Control and Prevention. Recommendations for the use of COVID-19 vaccines. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-co... . Assessed 4 Aug 2024.
-
- Korea Academy of Tuberculosis and Respiratory Disease. Korean Chronic Obstructive Lung Disease Guideline 2024. https://www.lungkorea.org/bbs/index.html?code=guide&category=&gu... . Assessed 12 Oct 2025.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
